Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04713319Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms). Primary endpoints: Acute change in blood IL-6, insulin, and glucose at Day 7 and Change in blood metrices from Day 1 to Day 7. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04713319.